- Home
- LUCD
as 07-01-2024 4:00pm EST
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 42.0M | IPO Year: | 2021 |
| Target Price: | $4.25 | AVG Volume (30 days): | 175.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.63 - $1.72 | Next Earning Date: | 08-12-2024 |
| Revenue: | $2,983,000 | Revenue Growth: | 370.50% |
| Revenue Growth (this year): | 132.78% | Revenue Growth (next year): | 179.95% |
Latest Lucid Diagnostics Inc. News
LUCD Breaking Stock News: Dive into LUCD Ticker-Specific Updates for Smart Investing
PR Newswire
20 days ago
4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing
Thomson Reuters StreetEvents
2 months ago
Q1 2024 PAVmed Inc Earnings Call
GuruFocus.com
2 months ago
Lucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
PR Newswire
2 months ago
PAVmed Provides Business Update and First Quarter 2024 Financial Results
PR Newswire
2 months ago
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
PR Newswire
2 months ago
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
PR Newswire
2 months ago
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors
PR Newswire
2 months ago
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024
Share on Social Networks:
Disclaimer
The information presented on this page, "LUCD Lucid Diagnostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.